Form 4: Privia Health Director David King Receives 8,396 Restricted Stock Units

Privia Health Group, Inc. Director David P. King reported the acquisition of 8,396 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Summary

• David P. King, a Director of Privia Health Group, Inc. (PRVA), acquired 8,396 shares of common stock on May 21, 2025.
• These shares were received as restricted stock units (RSUs) under the Issuer's 2021 Omnibus Incentive Plan, with an acquisition price of $0.
• Following this transaction, Mr. King beneficially owns a total of 42,312 shares of Privia Health Group, Inc. common stock.
• The restricted stock units are set to vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders or (ii) the first anniversary of the grant date (May 21, 2025).

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is a positive sign of aligning management interests with shareholder value, reflecting standard compensation practices and indicating continued commitment from the director.

Positives

• The grant of restricted stock units aligns the director's interests with long-term shareholder value, as the value of the units is tied to the company's stock performance.
• The transaction is part of an established incentive plan (2021 Omnibus Incentive Plan), indicating a structured approach to executive and director compensation.

Future Outlook

The restricted stock units granted to Director David P. King are scheduled to vest on the earlier of the day immediately preceding the Company's 2026 annual meeting of stockholders or the first anniversary of the grant date (May 21, 2025).

Industry Context

This Form 4 filing details a routine insider transaction, specifically an equity grant to a director, which is a common practice in publicly traded companies across all industries to incentivize and retain key personnel by aligning their financial interests with the company's long-term performance.

Corporate Governance

Related Party Transactions

• The grant of 8,396 restricted stock units to David P. King, a Director, constitutes a related party transaction as it involves compensation from the company to an insider.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director helps align the director's financial interests with the company's stock performance, potentially benefiting shareholders through improved long-term value creation.

Next Steps

• Vesting of the 8,396 restricted stock units on the earlier of the day preceding the 2026 annual meeting or May 21, 2026.

Key Dates

Keywords

Privia Health Group, PRVA, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership